CN102084251A - 用于急性冠状动脉疾病的生物标志物 - Google Patents

用于急性冠状动脉疾病的生物标志物 Download PDF

Info

Publication number
CN102084251A
CN102084251A CN2009801135145A CN200980113514A CN102084251A CN 102084251 A CN102084251 A CN 102084251A CN 2009801135145 A CN2009801135145 A CN 2009801135145A CN 200980113514 A CN200980113514 A CN 200980113514A CN 102084251 A CN102084251 A CN 102084251A
Authority
CN
China
Prior art keywords
anp
acd
level
antibody
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801135145A
Other languages
English (en)
Chinese (zh)
Inventor
克里斯托弗·约瑟夫·彭伯顿
阿瑟·马克·理查兹
迈克尔·加里·尼科尔斯
蒂莫西·格兰特·扬德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otago Innovation Ltd
Original Assignee
Otago Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otago Innovation Ltd filed Critical Otago Innovation Ltd
Publication of CN102084251A publication Critical patent/CN102084251A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CN2009801135145A 2008-02-22 2009-02-20 用于急性冠状动脉疾病的生物标志物 Pending CN102084251A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3062908P 2008-02-22 2008-02-22
US61/030,629 2008-02-22
PCT/NZ2009/000022 WO2009104974A2 (en) 2008-02-22 2009-02-20 Biomarkers

Publications (1)

Publication Number Publication Date
CN102084251A true CN102084251A (zh) 2011-06-01

Family

ID=40986076

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801135145A Pending CN102084251A (zh) 2008-02-22 2009-02-20 用于急性冠状动脉疾病的生物标志物

Country Status (7)

Country Link
US (1) US20110033874A1 (https=)
EP (1) EP2263086A4 (https=)
JP (1) JP2011514156A (https=)
CN (1) CN102084251A (https=)
AU (1) AU2009215996A1 (https=)
CA (1) CA2716280A1 (https=)
WO (1) WO2009104974A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106716123A (zh) * 2014-09-30 2017-05-24 深圳华大基因科技有限公司 冠心病患者特异性生物标志组合物及其用途
CN107076710A (zh) * 2014-09-30 2017-08-18 深圳华大基因科技有限公司 冠心病患者特异性生物标志组合物及其用途
CN111467497A (zh) * 2020-05-09 2020-07-31 复旦大学附属中山医院 Fto作为靶点在治疗压力负荷性心肌损伤中的应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2596010T3 (en) * 2010-07-19 2017-07-31 Otago Innovation Ltd SIGNAL biomarkers
WO2013033734A1 (en) 2011-09-02 2013-03-07 The Trustees Of Columbia University In The City Of New York Diagnosis and Treatment of Cancer Expressing ILT3 or ILT3 Ligand
CN102628864B (zh) * 2011-12-30 2014-08-13 北京九强生物技术股份有限公司 胶乳增强免疫比浊法测定血清或尿液中心脏型脂肪酸结合蛋白的试剂盒
CN102636651A (zh) * 2012-04-06 2012-08-15 上海领潮生物科技有限公司 多项心肌标志物并行检测方法及系统、芯片试纸
US10175250B2 (en) * 2012-06-11 2019-01-08 Gabriela Venturini Da Silva Nitrated cardiac troponin I as a biomarker of cardiac ischemia
WO2017015227A1 (en) 2015-07-17 2017-01-26 The Trustees Of Columbia University In The City Of New York Methods of treating cd166-expressing cancer
CN106370753B (zh) * 2016-10-26 2019-02-01 王喜军 冠心病尿液代谢标记物的鉴定及分析方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244904A1 (en) * 2003-10-29 2005-11-03 Leong Ng Diagnostics based on signal peptide detection
WO2006131529A1 (en) * 2005-06-07 2006-12-14 F. Hoffmann La-Roche Ag Use of nt-proanp and nt-probnp for diagnosing cardiac diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244904A1 (en) * 2003-10-29 2005-11-03 Leong Ng Diagnostics based on signal peptide detection
WO2006131529A1 (en) * 2005-06-07 2006-12-14 F. Hoffmann La-Roche Ag Use of nt-proanp and nt-probnp for diagnosing cardiac diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李永健等: "N-末端脑钠素与心钠素对冠心病慢性心力衰竭诊断及预后判断价值的比较研究", 《中国危重病急救医学》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106716123A (zh) * 2014-09-30 2017-05-24 深圳华大基因科技有限公司 冠心病患者特异性生物标志组合物及其用途
CN107076710A (zh) * 2014-09-30 2017-08-18 深圳华大基因科技有限公司 冠心病患者特异性生物标志组合物及其用途
CN107076710B (zh) * 2014-09-30 2019-10-25 深圳华大基因科技有限公司 冠心病患者特异性生物标志组合物及其用途
CN106716123B (zh) * 2014-09-30 2019-10-25 深圳华大基因科技有限公司 冠心病患者特异性生物标志组合物及其用途
CN111467497A (zh) * 2020-05-09 2020-07-31 复旦大学附属中山医院 Fto作为靶点在治疗压力负荷性心肌损伤中的应用
CN111467497B (zh) * 2020-05-09 2022-03-01 复旦大学附属中山医院 Fto作为靶点在治疗压力负荷性心肌损伤中的应用

Also Published As

Publication number Publication date
EP2263086A4 (en) 2012-10-17
CA2716280A1 (en) 2009-08-27
WO2009104974A3 (en) 2009-11-26
JP2011514156A (ja) 2011-05-06
WO2009104974A2 (en) 2009-08-27
AU2009215996A1 (en) 2009-08-27
EP2263086A2 (en) 2010-12-22
US20110033874A1 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
CA2662629C (en) Bnp signal peptide fragments for acute cardiac disorders
CN102084251A (zh) 用于急性冠状动脉疾病的生物标志物
US8507209B2 (en) Biomarkers
US10106575B2 (en) Biomarkers

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110601